EUVIMEDEUVIMED entdecken
Crossref

Enhancing Radiosensitivity in Prostate Adenocarcinoma by 7-Geranyloxycoumarin: The Potential Roles of β-Catenin, c-MYC, and PSMD10

Nafiseh Bagheri, Yasaman Abolhassani, Fatemeh B. Rassouli, Khadijeh Jamialahmadi

Pharmaceutical Sciences · 31.07.2026 · 32 (3) · 462-468

DOI: 10.34172/ps.43308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Sciences, online erschienen am 31.07.2026. Verfasst von Nafiseh Bagheri und 3 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prostate adenocarcinoma is commonly treated with radiation and chemotherapy, but resistance and toxicity limit their success, highlighting the need for novel radiosensitizers. We investigated the effects of 7-Geranyloxycoumarin, alone and in combination with radiation, on the expression of β-catenin (CTNNB1), c-MYC, and Gankyrin (PSMD10), key mediators of Wnt signaling pathway associated with radioresistance in prostate adenocarcinoma cells.

Methods

STRING and GEPIA2 were used for interactome mapping, pathway enrichment, and expression/survival validation in prostate adenocarcinoma. Human prostate adenocarcinoma (PC-3) cells were pretreated with 40 µM 7-Geranyloxycoumarin and subsequently irradiated with 4 Gy. Gene expression was assessed by real-time PCR after 72 h.

Results

In silico analyses confirmed interactions among CTNNB1, c-MYC, and PSMD10, their involvement in the Wnt pathway, and the overexpression and prognostic trends of c-MYC and PSMD10. In PC-3 cells, 7-Geranyloxycoumarin treatment significantly decreased c-MYC expression (P

Zitieren

APA

Bagheri, N., Abolhassani, Y., Rassouli, F. B., & Jamialahmadi, K. (2026). Enhancing Radiosensitivity in Prostate Adenocarcinoma by 7-Geranyloxycoumarin: The Potential Roles of β-Catenin, c-MYC, and PSMD10. Pharmaceutical Sciences, 32(3), 462-468. https://doi.org/10.34172/ps.43308

Vancouver

Bagheri N, Abolhassani Y, Rassouli FB, Jamialahmadi K. Enhancing Radiosensitivity in Prostate Adenocarcinoma by 7-Geranyloxycoumarin: The Potential Roles of β-Catenin, c-MYC, and PSMD10. Pharmaceutical Sciences. 2026;32(3):462-468. doi:10.34172/ps.43308

BibTeX
@article{Bagheri2026,
  author = {Bagheri, Nafiseh and Abolhassani, Yasaman and Rassouli, Fatemeh B. and Jamialahmadi, Khadijeh},
  title = {Enhancing Radiosensitivity in Prostate Adenocarcinoma by 7-Geranyloxycoumarin: The Potential Roles of β-Catenin, c-MYC, and PSMD10},
  journal = {Pharmaceutical Sciences},
  year = {2026},
  volume = {32},
  number = {3},
  pages = {462--468},
  doi = {10.34172/ps.43308}
}
Kostenlos starten →